24/7 Patient Assistance: 760-405-8205

Tania Kaprealian, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

specialties & services

  • Bio & Insurance Information

    Dr. Tania Kaprealian graduated from the University of California San Francisco. She did her internship at the VA Greater Los Angeles Healthcare System and completed her residency program at the UCSF. She is specialized in Radiation Oncology and board certified in Radiation Oncology. Dr. Kaprealian has been in practice for more 11 years and is affiliated with the Ronald Reagan UCLA Medical Center. During her career, she has also contributed to 7 research publications.



  • Education & Training

    dept_icon

    University of California San Francisco

    Medical School

    dept_icon

    VA Greater Los Angeles Healthcare System

    Internship

    dept_icon

    UCSF

    Residency

  • Board Certifications

    American Board of Radiology - Radiation Oncology

  • Hospital & Practice

    Ronald Reagan UCLA Medical Center

    Languages: English/Spanish

    (310) 825-9111

    757 Westwood Plaza

    Los Angeles, California 90095

    Read More
  • Publications & Memberships

    Dr. Tania Kaprealian has contributed to 3 publications.

    Predictors of recurrence following resection of intracranial chordomas.

    Choy, W.,Terterov, S.,Kaprealian, T. B.,Trang, A.,Ung, N.,DeSalles, A.,Chung, L. K.,Martin, N.,Selch, M.,Bergsneider, M.,Vinters, H. V.,Yong, W. H.,Yang, I.; J Clin Neurosci. 2015 Jul 27.

    See more >>

    Incorporating Cancer Stem Cells in Radiation Therapy Treatment Response Modeling and the Implication in Glioblastoma Multiforme Treatment Resistance.

    Yu, V. Y.,Nguyen, D.,Pajonk, F.,Kupelian, P.,Kaprealian, T.,Selch, M.,Low, D. A.,Sheng, K.; Int. J. Radiat. Oncol. Biol. Phys.. 2015 Mar 11.

    See more >>

    Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.

    Jabbari, S., Weinberg, V. K., Kaprealian, T., Hsu, I. C., Ma, L., Chuang, C., Descovich, M., Shiao, S., Shinohara, K., Roach, M., Gottschalk, A. R.; Int J Radiat Oncol Biol Phys. 2012 Jan 1.

    See more >>